These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6887929)

  • 1. The metabolism of aldosterone in kidney.
    McDermott M; Latif S; Morris DJ
    J Steroid Biochem; 1983 Aug; 19(2):1205-11. PubMed ID: 6887929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthesis of reduced metabolites of aldosterone by subcellular fractions of rat kidney: effects of antimineralocorticoids.
    McDermott MJ; Freiberger M; Latif SA; Morris DJ
    J Steroid Biochem; 1985 Oct; 23(4):503-9. PubMed ID: 4068711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of antimineralocorticoids on synthesis of aldosterone metabolites in target tissues.
    Morris DJ; McDermott MJ; Freiberger M; Latif SA; Pacholski M; Brem AS
    J Steroid Biochem; 1986 Jan; 24(1):341-4. PubMed ID: 3702416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of adrenalectomy and spironolactone on urinary metabolites of aldosterone in rats.
    Gorsline J; Morris DJ
    Steroids; 1988; 51(1-2):81-99. PubMed ID: 3242168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of mineralocorticoid agonists and antagonists on binding of 3 H-aldosterone to adrenalectomized rat kidney plasma membranes.
    Forte LR
    Life Sci I; 1972 May; 11(10):461-73. PubMed ID: 4348285
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of adrenal and gonadal steroids and K+-canrenoate on the metabolism of aldosterone by rat liver microsomes.
    Latif SA; McDermott MJ; Morris DJ
    Steroids; 1983 Sep; 42(3):283-97. PubMed ID: 6673191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible biological role of aldosterone metabolites.
    Morris DJ; Kenyon CJ; Latif SA; McDermott M; Goodfriend TL
    Hypertension; 1983; 5(2 Pt 2):I35-40. PubMed ID: 6826227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldosterone metabolism in combined isolated perfused rat liver and kidney.
    Egfjord M; Daugaard H; Olgaard K
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F536-48. PubMed ID: 2012206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
    Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
    Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic derivatives of aldosterone.
    Morris DJ; Brem AS
    Am J Physiol; 1987 Mar; 252(3 Pt 2):F365-73. PubMed ID: 3548434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone.
    Kenyon CJ; Brem AS; McDermott MJ; Deconti GA; Latif SA; Morris DJ
    Endocrinology; 1983 May; 112(5):1852-6. PubMed ID: 6403339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.
    Egfjord M
    Acta Physiol Scand Suppl; 1995; 627():1-42. PubMed ID: 8848946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal action of progesterone and 18-substituted derivatives.
    Rafestin-Oblin ME; Couette B; Barlet-Bas C; Cheval L; Viger A; Doucet A
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F828-32. PubMed ID: 1647687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid inhibition of mineralocorticoid action in the rat.
    Kenyon CJ; Saccoccio NA; Morris DJ
    Clin Sci (Lond); 1984 Sep; 67(3):329-35. PubMed ID: 6380888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.
    Wambach G; Casals-Stenzel J
    Biochem Pharmacol; 1983 May; 32(9):1479-85. PubMed ID: 6222738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced aldosterone metabolites in hypertension.
    Morris DJ
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):19-25. PubMed ID: 8481345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the antimineralocorticoid, spironolactone on the hepatic synthesis of polar metabolites of aldosterone in male rats.
    Tsai R; Davis RP; Morris DJ
    J Steroid Biochem; 1980 May; 13(5):481-7. PubMed ID: 7392625
    [No Abstract]   [Full Text] [Related]  

  • 20. Mode of spirolactone action: competitive inhibition of aldosterone binding to kidney mineralocorticoid receptors.
    Fanestil DD
    Biochem Pharmacol; 1968 Oct; 17(10):2240-2. PubMed ID: 5696892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.